Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.

Source:http://linkedlifedata.com/resource/pubmed/id/12378510

Download in:

View as

Triples

General Info

PMID
12378510